Cure8 research brief
Why This Matters
This project investigates how estrogen receptor signaling in intestinal epithelial cells drives sex-specific responses to injury and inflammation that may influence ulcerative colitis risk and progression.
Who Should Pay Attention
Researchers (sex differences, epithelial biology, IBD), clinicians caring for IBD patients, and patients curious about hormonal influences on gut inflammation
Study Snapshot
What To Know
The project will use mouse models (including ER knockouts), organoid assays, and molecular profiling to define how ERα and ERβ expression and signaling change after intestinal injury (DSS colitis) and how estrogen and inflammatory pathways converge in male versus female intestinal epithelial cells.
The investigators aim to produce a model explaining how altered estrogen signaling contributes to epithelial dysfunction and sex-specific colonic inflammation. The work is a basic/translational research project (funded) focused on mechanisms, not a clinical trial of a treatment.
Outcomes are intended to inform future personalized-medicine approaches by clarifying hormonal influences on intestinal inflammation.
Keep In Mind
Project-record describing funded basic and translational lab and mouse studies; not a clinical trial and not a report of patient outcomes. Translation to humans will require further study.
Source Details
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: National Institute of Diabetes and Digestive and Kidney Diseases - R56DK145554 - $300,000
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.